QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)

Sonnet BioTherapeutics (SONN) Institutional Ownership

$1.97
+0.19 (+10.67%)
(As of 02/29/2024 ET)

Institutional Ownership Changes (13F Filings) for Sonnet BioTherapeutics (NASDAQ:SONN)

Current
Institutional Ownership
Percentage
36.77%
Number of
Institutional Buyers
(last 12 months)
10
Total
Institutional Inflows
(last 12 months)
$51.39 M
Number of
Institutional Sellers
(last 12 months)
0
Get SONN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Sonnet BioTherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

SONN Institutional Buying and Selling by Quarter


Sonnet BioTherapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/15/2024Citadel Advisors LLC29,447$51K0.0%N/A0.959%
8/14/2023Two Sigma Securities LLC68,082$33K0.0%N/A0.248%
8/14/2023State Street Corp94,506$46K0.0%N/A0.344%
8/11/2023Renaissance Technologies LLC293,893$0.14M0.0%+1,714.2%1.069%
8/11/2023Geode Capital Management LLC169,392$83K0.0%+485.8%0.616%
7/27/2023Virtu Financial LLC86,624$42K0.0%N/A0.315%
5/19/2023Anson Funds Management LP1,760,000$0.63M0.1%N/A6.405%
5/16/2023CVI Holdings LLC701,634$0.25M0.1%N/A3.468%
5/16/2023Sabby Management LLC1,215,534$0.44M0.4%N/A6.008%
5/15/2023Anson Funds Management LP1,760,000$0.63M0.1%N/A8.699%
5/15/2023Boothbay Fund Management LLC136,231$49K0.0%N/A0.673%
2/13/2023Geode Capital Management LLC29,467$33K0.0%-43.3%0.344%
11/15/2022Vanguard Group Inc.133,811$0.20M0.0%-92.9%3.093%
11/7/2022Virtu Financial LLC26,914$40K0.0%N/A0.622%
8/15/2022State Street Corp130,288$36K0.0%+96.8%0.215%
8/2/2022Advisory Services Network LLC130,525$37K0.0%+158.3%0.215%
5/17/2022Virtu Financial LLC112,255$42K0.0%-56.1%0.185%
5/13/2022Renaissance Technologies LLC1,801,200$0.68M0.0%+438.1%2.989%
5/13/2022Vanguard Group Inc.1,681,785$0.63M0.0%-5.4%2.791%
5/10/2022Campion Asset Management90,612$34K0.0%N/A0.150%
8/16/2021State Street Corp62,688$99K0.0%N/A0.253%
8/13/2021Vanguard Group Inc.701,634$1.11M0.0%+416.0%2.834%
5/19/2021Virtu Financial LLC65,106$0.15M0.0%N/A0.371%
5/18/2021Citadel Advisors LLC113,264$0.26M0.0%N/A0.534%
5/18/2021Jane Street Group LLC17,304$39K0.0%N/A0.099%
5/17/2021Price T Rowe Associates Inc. MD45,100$0.10M0.0%N/A0.257%
5/13/2021Bank of New York Mellon Corp20,399$46K0.0%N/A0.116%
5/7/2021BlackRock Inc.255,761$0.58M0.0%+3.7%1.457%
3/26/2021Susquehanna International Group LLP15,434$34K0.0%N/A0.088%
2/9/2021Advisory Services Network LLC24,581$55K0.0%+32.3%0.143%
2/5/2021BlackRock Inc.246,555$0.55M0.0%+2.5%1.435%
11/19/2020Schonfeld Strategic Advisors LLC12,200$31K0.0%N/A0.071%
11/19/2020IHT Wealth Management LLC10,000$26K0.0%N/A0.058%
11/17/2020Schonfeld Strategic Advisors LLC12,200$31K0.0%N/A0.089%
(Data available from 1/1/2016 forward)













SONN Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of SONN shares?

During the previous two years, 13 institutional investors and hedge funds held shares of Sonnet BioTherapeutics. The most heavily invested institutionals were Anson Funds Management LP ($0.63M), Sabby Management LLC ($0.44M), CVI Holdings LLC ($0.25M), Vanguard Group Inc. ($0.20M), Renaissance Technologies LLC ($0.14M), Geode Capital Management LLC ($83K), and Citadel Advisors LLC ($51K).Learn more on SONN's institutional investors.

What percentage of Sonnet BioTherapeutics stock is owned by institutional investors?

36.77% of Sonnet BioTherapeutics stock is owned by institutional investors. Learn more on SONN's institutional investor holdings.

Which institutional investors have been buying Sonnet BioTherapeutics stock?

Of the 12 institutional investors that purchased Sonnet BioTherapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Anson Funds Management LP ($3.52M), Renaissance Technologies LLC ($1.74M), Sabby Management LLC ($1.22M), CVI Holdings LLC ($0.70M), State Street Corp ($0.16M), Geode Capital Management LLC ($0.14M), and Boothbay Fund Management LLC ($0.14M).

How much institutional buying is happening at Sonnet BioTherapeutics?

Institutional investors have bought a total of 7,998,323 shares in the last 24 months. This purchase volume represents approximately $245.01M in transactions.

Which Sonnet BioTherapeutics major shareholders have been selling company stock?

The following institutional investors have sold Sonnet BioTherapeutics stock in the last 24 months: Vanguard Group Inc. ($1.85M), Virtu Financial LLC ($0.14M), and Geode Capital Management LLC ($22.50K).

How much institutional selling is happening at Sonnet BioTherapeutics?

Institutional investors have sold a total of 2,015,026 shares in the last 24 months. This volume of shares sold represents approximately $84.90M in transactions.


This page (NASDAQ:SONN) was last updated on 2/29/2024 by MarketBeat.com Staff